Revolution Medicines, Inc. Common Stock (NASDAQ: RVMD) last traded at $188.44, down 2.84% on the session. The quote above updates while this page is open; the figures below are drawn from Revolution Medicines, Inc. Common Stock’s own filings and are restated only when a new one is published.
Revolution Medicines, Inc. Common Stock trades on NASDAQ under the ticker RVMD. Its market capitalisation is $40.39 billion.
Valuation measures for Revolution Medicines, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $40.39B |
|---|---|
| Enterprise value | $41.29B |
| Price / book | 15.50 |
| Beta | 1.17 |
Trailing-twelve-month figures tagged in Revolution Medicines, Inc. Common Stock's XBRL filings with the SEC.
| Revenue (TTM) |
|---|
| $0.00 |
| Net income (TTM) | -$1.77B |
|---|
| EPS (TTM) | -$8.86 |
|---|
| Return on equity | -67.85% |
|---|
| Cash | $815.43M |
|---|
Range and volume for RVMD over the past 52 weeks.
| 52-week high | $224.31 |
|---|---|
| 52-week low | $47.45 |
| Volume | 2.94M |
| Average volume | 1.96M |
| Previous close | $193.95 |
Invest a chosen dollar amount in Revolution Medicines, Inc. Common Stock with fractional shares.
Start investingCreate an account
Investing involves risk, including possible loss of principal. Nothing here is investment advice or a recommendation to buy or sell RVMD.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.